AQB - アクアバウンティ・テクノロジ― （AquaBounty Technologies Inc.） アクアバウンティ・テクノロジ―AQBのチャート
AQBの企業情報
| symbol | AQB |
|---|---|
| 会社名 | AquaBounty Technologies Inc （アクアバウンティ・テクノロジ―） |
| 分野（sector） | ― |
| 産業（industry） | ― |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 AquaBounty Technologies Inc. is a biotechnology company engaged in research development and commercialization of the commercial viability of a group of proteins antifreeze proteins (AFPs). The Company focuses on the managing aquaculture productivity. It offers AquAdvantage Salmon (AAS) which can be grown in contained land-based facilities. It offers AquAdvantage Salmon for land-based facilities that can be built closer to consumers to manage the need for air freight shipping and transportation. The Company's subsidiaries include AquaBounty Canada Inc. which operates a commercial biotechnology laboratory that conducts research and development programs related to the Company's technologies; AquaBounty Panama S. de R.L.; AquaBounty Farms Inc. and AquaBounty Brasil Participacoes Ltda. which conducts commercial trials of the Company's AquAdvantage Salmon. アクアバウンティ・テクノロジ―は米国のバイオテクノロジ―企業。サケの遺伝子組み換え技術「アクアドバンテ―ジ」による養殖サケの生産に従事する。また、サケの成長期間を短縮し生産性を向上させる技術の開発に取り組む。同社の「アクアドバンテ―ジ・サ―モン」は米国食品医薬品局(FDA)の認可を受けている。本社所在地はマサチュ―セッツ州メイナ―ド。 AquaBounty Technologies, Inc. is a leader in the field of land-based aquaculture and the use of technology for improving its productivity and sustainability. The Company's objective is to ensure the availability of high-quality seafood to meet global consumer demand, while addressing critical production constraints in the most popular farmed species. The Company's AquAdvantage fish program is based upon a single, specific molecular modification in fish that results in more rapid growth in early development. With aquaculture facilities located in Prince Edward Island, Canada, and Indiana, USA, AquaBounty is raising its disease-free, antibiotic-free salmon in land-based recirculating aquaculture systems, offering a reduced carbon footprint and no risk of pollution of marine ecosystems as compared to traditional sea-cage farming. |
| 本社所在地 | Two Mill_Main Place Suite 395 Maynard MA 01754 USA |
| 代表者氏名 | Ronald L. Stotish Ronald L. Stotish |
| 代表者役職名 | President Chief Executive Officer Executive Director |
| 電話番号 | +1 978-648-6000 |
| 設立年月日 | 33573 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 37人 |
| url | www.aquabounty.com |
| nasdaq_url | https://www.nasdaq.com/symbol/aqb |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -9.95695 |
| 終値（lastsale） | 3.09 |
| 時価総額（marketcap） | 39701481.84 |
| 時価総額 | 時価総額（百万ドル） 39.18755 |
| 売上高 | 売上高（百万ドル） 0.06700 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 38.64687 |
| 当期純利益 | 当期純利益（百万ドル） -10.34041 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Aquabounty Technologies Inc revenues increased 26% to $67K. Net loss increased 26% to $5.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects General and administrative increase of 55% to $3.2M (expense) Research and development increase of 12% to $1.9M (expense) Other Income (expense). |
AQBのテクニカル分析
AQBのニュース
AquaBounty Technologies – Consensus Indicates Potential 202.6% Upside 2023/02/06 11:49:53 DirectorsTalk
AquaBounty Technologies with ticker code (AQB) have now 4 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 5 and 1.79 and has a mean target at 3.45. Now with the previous closing price of 1.14 this is indicating there is a potential upside of 202.6%. The 50 day moving average now sits at 0.81 and the 200 day MA is 1.11. The company has a market capitalisation of $80m. Find out more information at: https://www.aquabounty.com The potential market cap would be $241m based on the market concensus. AquaBounty Technologies, a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.
AquaBounty Technologies Inc. (NASDAQ:AQB) Adds 17.68% In One Week: What’s Boosting Its Stock? 2023/01/28 16:00:00 Marketing Sentinel
In last trading session, AquaBounty Technologies Inc. (NASDAQ:AQB) saw 0.71 million shares changing hands with its beta currently measuring 1.13. Company’s recent per share price level of $1.14 trading at $0.09 or 8.57% at ring of the bell on the day assigns it a market valuation of $73.64M. That closing price of AQB’s stock is … AquaBounty Technologies Inc. (NASDAQ:AQB) Adds 17.68% In One Week: What’s Boosting Its Stock? Read More »
Ringing In The Change For A New Era Of Fishing 2023/01/10 14:20:00 The North America Newswire
By David Willey, Benzinga Read a recent profile of Nocera Inc. here Nocera Inc. CEO Jeff Cheng rang the Nasdaq Stock Exchange closing bell Sept. 29 as part of the celebratory recognition of the company’s official NASDAQ listing. The Tawainese company has recently sailed to its stardom partly through its emphasis on “budget fish” like tilapia and catfish. Tilapia has traditionally been considered a budget fish that has seen increasing popularity over the years. It has become the second-most farmed fish and is both imported and farmed domestically in the U.S. Since 2017, the price of tilapia exports has increased from around $4.81 per kilogram to $5.23 per kilogram. Tilapia saw record high prices in 2021 with U.S. consumption remaining high even as Asian exports faltered. And even as finfish drive the fresh fish price rise in 2022, tilapia prices outdistanced all other finfish, seeing a whopping 37% increase in July compared with last year. Consequently, some businesses see an opportunity to fish for bigger profits by increasing domestic tilapia production.
AquaBounty Technologies Inc. (NASDAQ: AQB): Can A Stock Be Down -63.79% YTD, And Still Be A Loser 2022/12/24 14:30:00 Marketing Sentinel
AquaBounty Technologies Inc. (NASDAQ:AQB)’s traded shares stood at 0.55 million during the last session, with the company’s beta value hitting 1.06. At the close of trading, the stock’s price was $0.76, to imply a decrease of -13.39% or -$0.12 in intraday trading. The AQB share’s 52-week high remains $2.37, putting it -211.84% down since that … AquaBounty Technologies Inc. (NASDAQ: AQB): Can A Stock Be Down -63.79% YTD, And Still Be A Loser Read More »
AquaBounty Technologies GAAP EPS of -$0.08 beats by $0.01, revenue of $0.65M misses by $0.37M (NASDAQ:AQB) 2022/11/08 13:55:47 Seeking Alpha
AquaBounty Technologies press release (AQB): Q3 GAAP EPS of -$0.08 beats by $0.01.Revenue of $0.65M (+41.3% Y/Y) misses by $0.37M.“Looking ahead into 2023, we believe the need…
Boom Or Bust? Where Will AquaBounty Technologies Inc. (NASDAQ: AQB) Stock Go Next? 2022/06/04 17:00:00 Marketing Sentinel
During the last session, AquaBounty Technologies Inc. (NASDAQ:AQB)’s traded shares were 0.47 million, with the beta value of the company hitting 1.22. At the end of the trading day, the stock’s price was $1.51, reflecting an intraday gain of 2.72% or $0.04. The 52-week high for the AQB share is $6.53, that puts it down … Boom Or Bust? Where Will AquaBounty Technologies Inc. (NASDAQ: AQB) Stock Go Next? Read More »
Proxy Advisory Firm ISS Recommends Vote “FOR” the Charter Amendment Proposal – To Increase the Number of Authorized Shares of Common Stock 2022/05/20 20:05:00 GlobeNewswire
MAYNARD, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced that leading proxy advisory firm Institutional Shareholder Services Inc. (ISS), in addition to the Company’s Board of Directors and proxy advisory firm Glass Lewis, has recommended that the Company’s stockholders vote in favor of the proposal to amend the Company’s Third Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company’s common stock, $0.001 par value per share, from 80,000,000 to 150,000,000 at the upcoming adjourned annual meeting of stockholders to be held on May 27, 2022 (“Annual Meeting”).
AquaBounty Technologies GAAP EPS of -$0.07 beats by $0.01, revenue of $0.96M beats by $0.29M (NASDAQ:AQB) 2022/05/05 13:02:53 Seeking Alpha
AquaBounty Technologies press release (AQB): Q1 GAAP EPS of -$0.07 beats by $0.01.Revenue of $0.96M (+1271.4% Y/Y) beats by $0.29M.Harvested 133 tons of genetically engineered…
AquaBounty Technologies Announces First Quarter 2022 Financial Results 2022/05/05 12:01:45 Investors Acqua Bounty
MAYNARD, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced the Company’s financial results for the quarter ended
AquaBounty Technologies Announces First Quarter 2022 Financial Results 2022/05/05 12:00:00 GlobeNewswire
MAYNARD, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced the Company’s financial results for the quarter ended March 31, 2022.
Boom Or Bust? Where Will AquaBounty Technologies Inc. (NASDAQ: AQB) Stock Go Next? 2022/06/04 17:00:00 Marketing Sentinel
During the last session, AquaBounty Technologies Inc. (NASDAQ:AQB)’s traded shares were 0.47 million, with the beta value of the company hitting 1.22. At the end of the trading day, the stock’s price was $1.51, reflecting an intraday gain of 2.72% or $0.04. The 52-week high for the AQB share is $6.53, that puts it down … Boom Or Bust? Where Will AquaBounty Technologies Inc. (NASDAQ: AQB) Stock Go Next? Read More »
Proxy Advisory Firm ISS Recommends Vote “FOR” the Charter Amendment Proposal – To Increase the Number of Authorized Shares of Common Stock 2022/05/20 20:05:00 GlobeNewswire
MAYNARD, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced that leading proxy advisory firm Institutional Shareholder Services Inc. (ISS), in addition to the Company’s Board of Directors and proxy advisory firm Glass Lewis, has recommended that the Company’s stockholders vote in favor of the proposal to amend the Company’s Third Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company’s common stock, $0.001 par value per share, from 80,000,000 to 150,000,000 at the upcoming adjourned annual meeting of stockholders to be held on May 27, 2022 (“Annual Meeting”).
AquaBounty Technologies GAAP EPS of -$0.07 beats by $0.01, revenue of $0.96M beats by $0.29M (NASDAQ:AQB) 2022/05/05 13:02:53 Seeking Alpha
AquaBounty Technologies press release (AQB): Q1 GAAP EPS of -$0.07 beats by $0.01.Revenue of $0.96M (+1271.4% Y/Y) beats by $0.29M.Harvested 133 tons of genetically engineered…
AquaBounty Technologies Announces First Quarter 2022 Financial Results 2022/05/05 12:01:45 Investors Acqua Bounty
MAYNARD, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced the Company’s financial results for the quarter ended
AquaBounty Technologies Announces First Quarter 2022 Financial Results 2022/05/05 12:00:00 GlobeNewswire
MAYNARD, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced the Company’s financial results for the quarter ended March 31, 2022.